Literature DB >> 19233535

Enzyme replacement therapy with agalsidase alfa in pregnant women with Fabry disease.

G Kalkum, D Macchiella, J Reinke, H Kölbl, M Beck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19233535     DOI： 10.1016/j.ejogrb.2009.01.007

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN： 0301-2115            Impact factor:   2.435


× No keyword cloud information.
  5 in total

Review 1.  Pregnancy in women with inherited metabolic disease.

Authors:  Elaine Murphy
Journal:  Obstet Med       Date:  2015-03-29

2.  Prevalence of symptoms in female Fabry disease patients: a case-control survey.

Authors:  Machtelt G Bouwman; Saskia M Rombach; Erica Schenk; Annelies Sweeb; Frits A Wijburg; Carla E M Hollak; Gabor E Linthorst
Journal:  J Inherit Metab Dis       Date:  2012-03-20       Impact factor: 4.982

Review 3.  Fabry disease.

Authors:  Dominique P Germain
Journal:  Orphanet J Rare Dis       Date:  2010-11-22       Impact factor: 4.123

4.  Brazilian consensus recommendations for the diagnosis, screening, and treatment of individuals with fabry disease: Committee for Rare Diseases - Brazilian Society of Nephrology/2021.

Authors:  Cassiano Augusto Braga Silva; Luis Gustavo Modelli de Andrade; Maria Helena Vaisbich; Fellype de Carvalho Barreto
Journal:  J Bras Nefrol       Date:  2022 Apr-Jun

5.  Anaesthetic management of two patients with pompe disease for caesarean section.

Authors:  I J J Dons-Sinke; M Dirckx; G P Scoones
Journal:  Case Rep Anesthesiol       Date:  2014-03-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.